The Center for Diabetes Technology (CDT) has pursued a path to advance the use of technology, including analytics, to allow improved management, monitoring, and therapies for patients with Type 1 Diabetes.
Now, CDT is a recognized world leader in the technological treatment of diabetes and the hub of an international research network of leading U.S. institutions (Harvard, Stanford, Yale, Mayo Clinic, Mt. Sinai School of Medicine) and worldwide groups in Italy, France, Holland, and Argentina.
Researchers at the UVA Center for Diabetes Technology have spent years developing a smartphone that acts as an artificial pancreas – a device that automatically regulates blood sugar levels through customized insulin delivery.
In the new University of Virginia School of Medicine Research in Motion video series, researchers were asked three questions: What do you do? What do you love about your research? How will it impact human health?
Our Directer, Boris Kovatchev, Ph.D, was excited to share his answers in last weeks’ 2-minute video. We hope you enjoy watching as we celebrate all the compelling and inspiring work done by School of Medicine researchers at the UVA Center for Diabetes Technology.
The Center was recently honored by JDRF for its pioneering work in the development of Artificial Pancreas technology.
"Any sufficiently advanced technology is indistinguishable from Magic." -Arthur C. Clark
Support our work and efforts to help fund innovative Type 1 Diabetes research.